Mawer Investment Management Ltd. Grows Stake in Danaher Corporation (NYSE:DHR)

Key Points

• Mawer Investment Management Ltd. increased its stake in Danaher Corporation by 1.8%, now owning 434,608 shares valued at approximately $89.1 million.
• Multiple institutional investors have also raised their positions in Danaher, with 79.05% of the company's stock owned by institutional investors and hedge funds.
• Danaher announced a quarterly dividend of $0.32 per share, representing an annualized yield of 0.63% and a dividend payout ratio of 27.23%.

Mawer Investment Management Ltd. boosted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 1.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 434,608 shares of the conglomerate's stock after buying an additional 7,756 shares during the period. Mawer Investment Management Ltd. owned approximately 0.06% of Danaher worth $89,095,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. raised its position in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Heck Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter worth about $27,000. Sierra Ocean LLC boosted its position in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new stake in Danaher in the 1st quarter valued at approximately $31,000. Finally, Hurley Capital LLC acquired a new position in Danaher during the fourth quarter valued at approximately $34,000. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

DHR has been the subject of several research reports. Leerink Partners lifted their price target on Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a report on Wednesday, April 23rd. Evercore ISI reduced their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Barclays reiterated an "overweight" rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Bank of America dropped their price objective on Danaher from $265.00 to $230.00 in a research note on Monday, April 14th. Finally, Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Price Performance

NYSE DHR traded down $1.32 during trading hours on Friday, reaching $195.84. 3,952,073 shares of the stock traded hands, compared to its average volume of 4,302,104. The stock has a 50 day simple moving average of $197.25 and a two-hundred day simple moving average of $202.96. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company has a market cap of $140.23 billion, a price-to-earnings ratio of 41.64, a price-to-earnings-growth ratio of 2.83 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.72 earnings per share. On average, analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 25th. Investors of record on Friday, June 27th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.7%. Danaher's dividend payout ratio (DPR) is presently 27.23%.

Insider Transactions at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 11.10% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.